Cardlytics, Inc. Common Stock earnings per share and revenue
On Nov 05, 2025, CDLX reported earnings of -0.07 USD per share (EPS) for Q3 25, beating the estimate of -0.15 USD, resulting in a 54.25% surprise. Revenue reached 52.03 million, compared to an expected 55.35 million, with a -5.99% difference. The market reacted with a -28.41% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of -0.07 USD, with revenue projected to reach 55.54 million USD, implying an increase of 0.00% EPS, and increase of 6.74% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Trane Technologies plc
Report Date
Jan 29, 2026 For Q4 25
Estimate
$2.89
Actual
$2.86
Surprise
-1.24%
SLB Limited
Report Date
Jan 23, 2026 For Q4 25
Estimate
$0.74
Actual
$0.78
Surprise
+4.25%
FAQ
What were Cardlytics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Cardlytics, Inc. Common Stock reported EPS of -$0.07, beating estimates by 54.25%, and revenue of $52.03M, -5.99% below expectations.
How did the market react to Cardlytics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -28.41%, changed from $1.76 before the earnings release to $1.26 the day after.
When is Cardlytics, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 03, 2026.
What are the forecasts for Cardlytics, Inc. Common Stock's next earnings report?
Based on --
analysts, Cardlytics, Inc. Common Stock is expected to report EPS of -$0.07 and revenue of $55.54M for Q4 2025.